Fig. 8: Summary.
Targeting ischemia-induced KCC2 hypofunction with the KCC2 functional enhancer CLP290 rescued refractory neonatal seizures at P7 and mitigated epileptogenesis in same pups at P12.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.